C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/57 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) C12N 9/48 (2006.01) C12N 15/62 (2006.01) C12N 15/85 (2006.01) C12N 15/87 (2006.01) C12P 13/00 (2006.01)
Patent
CA 2409679
The present invention relates to bacterial carboxypeptidases for use in gene directed prodrug therapy, in particular for use in the treatment of disease, including tumours. Specifically, the invention relates to modified bacterial carboxypeptidases which have enhanced catalytic activity.
La présente invention concerne des carboxypeptidases bactériennes destinées à être utilisées en thérapie par promédicaments ayant une action sur les gènes, en particulier pour traiter certaines maladies, notamment les tumeurs. Particulièrement, cette invention concerne des carboxypeptidases bactériennes modifiées présentant une activité catalytique accrue.
Marais Richard Malcolm
Spooner Robert
Springer Caroline Joy
Cancer Research Campaign Technology Limited
Marais Richard Malcolm
Smart & Biggar
Spooner Robert
Springer Caroline Joy
LandOfFree
Bacterial carboxypeptidase cpg2 variants and their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacterial carboxypeptidase cpg2 variants and their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacterial carboxypeptidase cpg2 variants and their use in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1656773